Literature DB >> 27011293

Afferent visual pathways in multiple sclerosis: a review.

Stuart L Graham1,2, Alexander Klistorner1,2.   

Abstract

Multiple sclerosis (MS) is a disease of the central nervous system that involves inflammation and demyelination at multiple sites and causes a wide variety of clinical presentations with variable neurological deficits. The visual pathways are frequently involved with either visual or motor dysfunction. Optic neuritis (ON) is one the most common and best characterized presentations of the disease, but there are many other manifestations depending on the site of the lesion. Eyes that have never had ON show slow progressive loss of axons and retinal ganglion cells. Previously unrecognized optic radiation lesions may be associated with residual latency delays on visual evoked potentials. Both anterograde and retrograde degeneration may occur along the visual pathway. This review covers the features of MS in the anterior and posterior visual system and describes advances that have been made with newer techniques such as retinal optical coherence tomography (OCT), magnetic resonance imaging (MRI) with diffusion tensor imaging and probabilistic tractography (DTI) and multifocal visual evoked potentials (mfVEPs). We report on the inter-relationship between these measures of structure and function, and how they may be used as biomarkers for the disease.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  multiple sclerosis; neuro-imaging; neuro-ophthalmology; optic neuritis; optic radiations

Mesh:

Year:  2016        PMID: 27011293     DOI: 10.1111/ceo.12751

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  18 in total

1.  Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.

Authors:  Athina Papadopoulou; Laura Gaetano; Armanda Pfister; Anna Altermatt; Charidimos Tsagkas; Felix Morency; Alexander U Brandt; Martin Hardmeier; Mallar M Chakravarty; Maxime Descoteaux; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  Neurology       Date:  2019-04-10       Impact factor: 9.910

2.  Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosis.

Authors:  Nicholas A Hubbard; Monroe P Turner; Minhui Ouyang; Lyndahl Himes; Binu P Thomas; Joanna L Hutchison; Shawheen Faghihahmadabadi; Scott L Davis; Jeremy F Strain; Jeffrey Spence; Daniel C Krawczyk; Hao Huang; Hanzhang Lu; John Hart; Teresa C Frohman; Elliot M Frohman; Darin T Okuda; Bart Rypma
Journal:  Hum Brain Mapp       Date:  2017-08-16       Impact factor: 5.038

Review 3.  Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.

Authors:  Elizabeth Silbermann; Lindsey Wooliscroft; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-19       Impact factor: 5.081

4.  Multifocal visual evoked potentials and contrast sensitivity correlate with ganglion cell-inner plexiform layer thickness in multiple sclerosis.

Authors:  Divya Narayanan; Han Cheng; Rosa A Tang; Laura J Frishman
Journal:  Clin Neurophysiol       Date:  2018-11-13       Impact factor: 3.708

5.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

6.  Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis.

Authors:  Dragana Drobnjak Nes; Pål Berg-Hansen; Sigrid A de Rodez Benavent; Einar A Høgestøl; Mona K Beyer; Daniel A Rinker; Nina Veiby; Mia Karabeg; Beáta Éva Petrovski; Elisabeth G Celius; Hanne F Harbo; Goran Petrovski
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

7.  Objective perimetry and progression of multiple sclerosis.

Authors:  Ted Maddess; Corinne F Carle; Emilie M F Rohan; Jonathan Baird-Gunning; Josh P van Kleef; Christian J Lueck
Journal:  eNeurologicalSci       Date:  2022-10-08

8.  Modulation of the zebrafish optokinetic reflex by pharmacologic agents targeting GABAA receptors.

Authors:  Enhua Shao; Seth D Scheetz; Wenting Xie; Edward A Burton
Journal:  Neurosci Lett       Date:  2018-02-02       Impact factor: 3.046

9.  An open-source method to analyze optokinetic reflex responses in larval zebrafish.

Authors:  Seth D Scheetz; Enhua Shao; Yangzhong Zhou; Clinton L Cario; Qing Bai; Edward A Burton
Journal:  J Neurosci Methods       Date:  2017-10-16       Impact factor: 2.390

10.  Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple Sclerosis.

Authors:  Nicholas A Hubbard; Yoel Sanchez Araujo; Camila Caballero; Minhui Ouyang; Monroe P Turner; Lyndahl Himes; Shawheen Faghihahmadabadi; Binu P Thomas; John Hart; Hao Huang; Darin T Okuda; Bart Rypma
Journal:  Brain Sci       Date:  2017-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.